Open access · CC-BY
via OpenAlex
Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging
Aging · 2026
Mitochondrial dysfunction
Altered intercellular communication
Disabled macroautophagy
Gene therapy
Telomerase activation
Human
Abstract
Mitochondrial DNA mutations can contribute to respiratory dysfunction and aging phenotypes, but they have not been established as the universal initiating cause of human aging.This Perspective compares mitochondrial transplantation with a proposed gene therapy strategy without presuming therapeutic superiority.Transplantation supplies functional organelles and has encouraging evidence in selected models and small clinical studies of acute injury.Gene transfer could support sustained endogenous mitochondrial maintenance, although that advantage remains untested for systemic aging.Four candidate mechanisms are considered: TERT associated mitochondrial protection, TFEB mediated lysosomal quality control, POLG and TFAM dependent genome maintenance with selective respiratory subunit supplementation, and FGF21 mediated metabolic signaling.Their evidence ranges from cellular mechanisms and animal studies to clinical experience in distinct disease indications.Important limitations include tumor promotion, inappropriate autophagy(definition) or genome packaging, endocrine adverse effects, vector toxicity, and uncertain coordination of multiple transgenes.A staged comparison should measure tissue specific target engagement, pathogenic heteroplasmy, respiratory function, organ performance, and long-term safety.Neither approach has demonstrated systemic human age reversal.The proposed framework is a falsifiable research agenda, with potential complementarity between organelle replacement and endogenous maintenance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.206440
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Sewell, P.E. (2026). Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging. <em>Aging</em>. https://doi.org/10.18632/aging.206440
Vancouver
Sewell PE. Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging. Aging. 2026. doi:10.18632/aging.206440.
BibTeX
@article{patrick2026Geneth,
title = {Gene therapy and mitochondrial transplantation for mitochondrial dysfunction in aging},
author = {Patrick E. Sewell},
journal = {Aging},
year = {2026},
doi = {10.18632/aging.206440},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Cell and Developmental Biology 2023
Open access · CC-BY
Dysregulated proteostasis network in neuronal diseases
Degenerative Neurological and Neuromuscular Disease 2026
Open access · CC-BY
Spermidine in Alzheimer’s Disease: Evidence from Animal Models and Human Studies
Frontiers in Aging 2022
Open access · CC-BY
Temperature-Dependent Regulation of Proteostasis and Longevity
Degenerative neurological and neuromuscular disease 2026
Open access · OA
Spermidine in Alzheimer's Disease: Evidence from Animal Models and Human Studies.
Cold Spring Harbor Perspectives in Biology 2011
Preprint · OA
Quality Control of Mitochondrial Proteostasis
Infoscience (Ecole Polytechnique Fédérale de Lausanne) 2021
Preprint · OA